Cilnidipine
| |
| Cilnidipine
| |
| Systematic (IUPAC) name | |
| O3-(2-methoxyethyl) O5-[(E)-3-phenylprop-2-enyl] 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine- 3,5-dicarboxylate | |
| Identifiers | |
| CAS number | ? |
| ATC code | C08 |
| PubChem | |
| Chemical data | |
| Formula | C27H28N2O7 |
| Mol. mass | 492.52 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Cilnidipine (INN) is a calcium channel blocker.
Calcium channel blockers (C08) | |
|---|---|
| Dihydropyridines | Amlodipine • Aranidipine • Azelnidipine • Barnidipine • Benidipine • Cilnidipine • Clevidipine • Efonidipine • Felodipine • Isradipine • Lacidipine • Manidipine • Lercanidipine • Nicardipine • Nifedipine • Nilvadipine • Nimodipine • Nisoldipine • Nitrendipine • Pranidipine |
| Phenylalkylamines | Gallopamil • Verapamil |
| Benzothiazepines | Diltiazem |
| Others | Naftopidil |
Navigation WikiDoc | WikiPatient | Popular pages | Recently Edited Pages | Recently Added
Pictures
There is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies
Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs
Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link HereThere is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies
